Patrick Machado

Patrick Machado

Country

Australia

Occupation

Business

Description

Member of the Board of Directors of Prota Therapeutics, Alumis, Acelyrin, Xenon Pharmaceuticals, and many other pharmaceutical and biotherapeutic companies. Co-founded and served as Chief Financial Officer and Chief Business Officer at Medivation, Inc. until his retirement in 2014 and served as a member of Medivation’s board of directors from 2014 until its acquisition for approximately $14 billion by Pfizer in 2016. Lawyer.

See Also

• LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies
• Noteworthy LGBTQ Individuals in the Accounting Profession

Further Reading/Research

• https://www.linkedin.com/in/patrick-machado-8b197aaa/
• https://investor.xenon-pharma.com/board-member/patrick-machado

Share on Facebook

Tweet